Since GSK‐3β is concentrated in the central nervous system, GSK‐3β activity disorder can lead to the occurrence and development of various nervous system diseases, such as stroke, neurodegenerative diseases (AD), epilepsy, and spinal cord injury.44 This evidence concerns the gene GSK3B and stroke disorder.